Acadia Healthcare Company, Inc. (Nasdaq: ACHC) acquired CRC Health Group, Inc. (CRC), a leading provider of treatment services related to substance abuse and other addiction and behavioral disorder, for $1.3 billion. At the time of closing, CRC operated 35 inpatient facilities with over 2,400 beds and 81 comprehensive treatment centers located in 30 states, and treated approximately 44,000 patients per day. The CRC acquisition was transformational for Acadia and represented the company's entry into the substance abuse market.
Waller assisted Acadia in all aspects of the transaction, including challenging real estate issues, Hart-Scott-Rodino compliance, and regulatory approvals. In addition, both CRC and Acadia had significant private equity ownership stakes, further complicating the dynamics. Extensive negotiations among the significant stockholders on matters of registration rights and other stockholder matters were required. Moreover, a portion of the consideration paid was in the form of Acadia stock requiring extensive securities law analysis and structuring. In addition to its role on the acquisition transaction, Waller acted as lead counsel to Acadia in financing the acquisition.
Acadia is the leading publicly traded pure-play provider of behavioral healthcare services, with operations in the United States and the United Kingdom.
Served as lead transaction counsel to Surgery Partners in its acquisition of Delaware Outpatient Center for Surgery, a multi-specialty facility in Newark, Delaware.
Represented HCA in its sale of InterMedHx, a provider of healthcare technology solutions, to Cerner.
Served as lead transaction counsel to HCA Healthcare, Inc. (HCA) and its investment entity, Health Insight Capital, in its investment in Intelligent InSites.
View More of Matt's Experience